Olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

被引：0
|
作者：
Thase, M. E. [1 ]
Corya, S. A. [1 ]
Osuntokun, O. [1 ]
Sanger, T. M. [1 ]
Case, M. [1 ]
Watson, S. B. [1 ]
Dube, S. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA 15260 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S235 / S236
页数：2
相关论文
共 50 条
  • [1] Olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder
    Thase, ME
    Corya, SA
    Osuntokun, O
    Sanger, TM
    Case, M
    Watson, SB
    Dubé, S
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 210S - 210S
  • [2] A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder
    Thase, Michael E.
    Corya, Sara A.
    Osuntokun, Olawale
    Case, Michael
    Henley, David B.
    Sanger, Todd M.
    Watson, Susan B.
    Dube, Sanjay
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) : 224 - 236
  • [3] Safety and efficacy of olanzapine plus fluoxetine in treatment-resistant major depressive disorder
    Shelton, R
    Tollefson, GD
    Tohen, M
    Jacobs, T
    Buras, W
    Spencer, K
    Gannon, KS
    Stahl, S
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 297 - 298
  • [4] Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
    Brunner, Elizabeth
    Tohen, Mauricio
    Osuntokun, Olawale
    Landry, John
    Thase, Michael E.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (11) : 2549 - 2559
  • [5] Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
    Elizabeth Brunner
    Mauricio Tohen
    Olawale Osuntokun
    John Landry
    Michael E Thase
    [J]. Neuropsychopharmacology, 2014, 39 : 2549 - 2559
  • [6] Olanzapine-fluoxetine combination in treatment-resistant depression
    Dube, S
    Paul, S
    Sanger, T
    Van Campen, L
    Corya, S
    Tollefson, G
    [J]. EUROPEAN PSYCHIATRY, 2002, 17 : 98S - 98S
  • [7] The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features
    Shelton, RC
    Tohen, M
    Stahl, S
    Jacobs, T
    Gannon, K
    Tollefson, GD
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 193 - 193
  • [8] Peripheral edema in an individual with treatment resistant major depressive disorder treated with olanzapine/fluoxetine combination
    Srikanthan, Camellia
    Niciforos, Elaina
    McNeill, David
    [J]. UNIVERSITY OF TORONTO MEDICAL JOURNAL, 2021, 98 (01) : 100 - 102
  • [9] A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
    Corya, Sara A.
    Williamson, Doug
    Sanger, Todd M.
    Briggs, Susan D.
    Case, Michael
    Tollefson, Gary
    [J]. DEPRESSION AND ANXIETY, 2006, 23 (06) : 364 - 372
  • [10] Onset of action of olanzapine-fluoxetine combination for treatment-resistant depression
    Dube, S
    Andersen, SW
    Briggs, SD
    Van Campen, LE
    Sanger, TM
    Thase, ME
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S186 - S186
12345